Under current law, Medicare’s prescription drug benefit (Part D) excludes “agents when used for anorexia, weight loss, or weight gain”. This exclusion has prevented Medicare from covering obesity medications and has allowed Medicaid plans to opt out of providing such coverage. For more than a decade, the OAC has pursued both legislative and regulatory pathways
Read Article

Obesity affects everyone differently, but for women, the impact can be more severe, as they face higher risks for related physical and mental health problems. A 2021 study in the Journal of Mid-Life Health found that women with obesity are twice as likely to die from related health issues compared to men with excess weight.
Read Article

Congress must support bipartisan legislation that will ensure Medicare beneficiaries can access safe, effective, and life-saving treatments for obesity. Update: On November 26th, the White House announced a to expand coverage for obesity medications under Medicare and Medicaid. Click here to learn more about what this means for patients.  The Treat and Reduce Obesity Act
Read Article